JUBILANT.NS - Jubilant Life Sciences Limited

NSE - NSE Real Time Price. Currency in INR

Jubilant Life Sciences Limited

1A, Sector 16A
Noida 201301
India
91 12 0436 1000
http://www.jubl.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees7,600

Key Executives

NameTitlePayExercisedYear Born
Mr. Hari Shanker BhartiaCo-Chairman & MDN/AN/A1956
Mr. Rajagopal Sankaraiah B.Sc., CAChief Financial Officer and Exec. Director of Fin.39.43MN/A1959
Mr. Umesh Mehta B.Sc., PGLSCMChief Information OfficerN/AN/A1966
Mr. Rajiv ShahCompliance Officer and Company Sec.5.61MN/AN/A
Dr. Raju MistryChief HR OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Jubilant Life Sciences Limited manufactures and supplies active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products, advance intermediates, fine ingredients, crop science ingredients, life science chemicals, and nutritional products. It offers APIs in the therapeutic areas of cardiovascular system, central nervous system, and anti-allergy streams; and develops multiple dosage forms, including oral solid, injectable, and ophthalmic dosage forms. The company also engages in the contract manufacturing of sterile injectables, ointment, creams and liquids, allergy therapy products, and radiopharmaceutical products; manufacture and market of radiopharmaceuticals for the diagnosis, treatment, and monitoring of various diseases; business of licensing generic dosage forms and providing regulatory services to generic pharmaceutical companies; and supply of generic dosage forms and bulk chemicals, such as ethyl acetate, acetic anhydride, etc., as well as vitamins to the European markets. In addition, it offers drug discovery services to pharmaceutical and biotech companies; clinical research data management services; channel screening services; and services in synthetic organic chemistry, combinatorial chemistry, medicinal chemistry, process research and development and manufacturing, scale up services, and GMP manufacturing-clinical supply to drug discovery companies of the United States, Europe, and internationally. Further, the company sells and distributes APIs in North America; and trades in advance intermediates, specialty ingredients, and nutrition products to pharmaceutical, animal feed and agrochemical industries in China. The company was formerly known as Jubilant Organosys Limited and changed its name to Jubilant Life Sciences Limited in 2010. The company was incorporated in 1978 and is based in Noida, India.

Corporate Governance

Jubilant Life Sciences Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.